Recent Posts
- NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
- NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
- NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
- NeonMind Announces DTC Eligibility
- NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation ‘Mindful Blend’
Recent Comments